After criticism, FDA pledges to revamp its tobacco division

The U.S. Food and Drug Administration's heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities.
The U.S. Food and Drug Administration’s heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities.